ADIAL PHARMACEUTICALS, INC. — Form 8-K
Filed October 2, 2026 · analyzed by the 8-K Agent
8-K
— Neutral
significance 12/100
What the filing says
Adial Pharmaceuticals filed a Form 8-K on October 2, 2026 for a period ending October 1, 2026, reporting under Item 8.01 (Other Events). The filing document itself is not provided in the text, so the specific content of the disclosed event cannot be determined. No financial figures, counterparties, or material details are present in this submission index.
Why this rating
Filing index only; substantive event details absent. Cannot assess materiality without actual disclosure content.
Extracted items
See more from October 2, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.